Home›Companies›Healthcare›Wellinks

Convexity Scientific Inc.

Virtual care and monitoring for people living with COPD.

Updated Nov 9, 2026·Latest SEC filing Aug 7, 2026·Suggest an edit

About Wellinks

Wellinks is a private company based in New Haven, Connecticut. It has reported $49,897,274 raised in seven offerings on Form D since May 2016. Its chief executive is Jennifer Barretta.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 23, 2026Aug 7, 2026$10,047,157of $13.0M target7$1.4MEquity, Options, Securities on exerciseRule 506(b)Form D ↗
Feb 13, 2026Mar 2, 2026amended Aug 7, 2026$2,713,285of $2.9M target5$542KDebt, Options, Securities on exerciseRule 506(b)Form D/A ↗1 earlier filing
Nov 17, 2025Dec 2, 2025$5,904,136of $6.2M target6$984KEquity, Options, Securities on exerciseRule 506(b)Form D ↗
May 7, 2025Jun 27, 2025$2,432,748of $3.5M target5$486KDebt, Options, Securities on exerciseRule 506(b)Form D ↗
Oct 29, 2021Nov 9, 2021$24,999,948fully sold7$3.5MEquityRule 506(b)Form D ↗
Sep 18, 2019Oct 16, 2019$3,500,000of $14.8M target3$1.1MEquityRule 506(b)Form D ↗
Apr 26, 2016May 2, 2016$300,000of $600K target12$25,000Equity, DebtRule 506(b)Form D ↗
Total, seven offerings$49,897,274

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Wellinks's Form D filed Aug 7, 2026.

Kevin Rakin
Kevin Rakin
Director
Also a director at Allyx Therapeutics.
HW
AA
JB
Jennifer Barretta
Chief Executive Officer
MW
Mike Waters
Director

Earlier filings also listed Richard Wilmot (director, last listed Dec 2025), Ilaa Agarwal (executive officer, last listed Dec 2025), Douglas Wenners (director, last listed Dec 2025), Abi Sundaramoorthy (executive officer, last listed Dec 2025), Stacie Bratcher (chief executive officer, last listed Jun 2025), Ryan McMillian (executive officer, last listed Nov 2021), Geoff Matous (executive officer, last listed Nov 2021) and Alex Waldron (chief executive officer and director, last listed Nov 2021).

Sources

  1. SECConvexity Scientific Inc. Form D, filed Mar 2, 2026
  2. SECConvexity Scientific Inc. filing history
  3. PressWellinks funding announcement
  4. ResearchWellinks clinical research study